These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

502 related items for PubMed ID: 16785694

  • 1. Nosocomial outbreak of ceftazidime-resistant Serratia marcescens strains that produce a chromosomal AmpC variant with N235K substitution.
    Yatsuyanagi J, Saito S, Konno T, Harata S, Suzuki N, Kato J, Amano K.
    Jpn J Infect Dis; 2006 Jun; 59(3):153-9. PubMed ID: 16785694
    [Abstract] [Full Text] [Related]

  • 2. Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate.
    Hidri N, Barnaud G, Decré D, Cerceau C, Lalande V, Petit JC, Labia R, Arlet G.
    J Antimicrob Chemother; 2005 Apr; 55(4):496-9. PubMed ID: 15722393
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit.
    Crivaro V, Bagattini M, Salza MF, Raimondi F, Rossano F, Triassi M, Zarrilli R.
    J Hosp Infect; 2007 Oct; 67(2):135-41. PubMed ID: 17884248
    [Abstract] [Full Text] [Related]

  • 6. Resistance to cefepime and cefpirome due to a 4-amino-acid deletion in the chromosome-encoded AmpC beta-lactamase of a Serratia marcescens clinical isolate.
    Mammeri H, Poirel L, Bemer P, Drugeon H, Nordmann P.
    Antimicrob Agents Chemother; 2004 Mar; 48(3):716-20. PubMed ID: 14982755
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.
    Odeh R, Kelkar S, Hujer AM, Bonomo RA, Schreckenberger PC, Quinn JP.
    Clin Infect Dis; 2002 Jul 15; 35(2):140-5. PubMed ID: 12087519
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complete Sequence of Four Multidrug-Resistant MOBQ1 Plasmids Harboring blaGES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada.
    Boyd D, Taylor G, Fuller J, Bryce E, Embree J, Gravel D, Katz K, Kibsey P, Kuhn M, Langley J, Mataseje L, Mitchell R, Roscoe D, Simor A, Thomas E, Turgeon N, Mulvey M, Canadian Nosocomial Infection Surveillance Program.
    Microb Drug Resist; 2015 Jun 15; 21(3):253-60. PubMed ID: 25545311
    [Abstract] [Full Text] [Related]

  • 13. Nosocomial neonatal outbreak of Serratia marcescens--analysis of pathogens by pulsed field gel electrophoresis and polymerase chain reaction.
    Steppberger K, Walter S, Claros MC, Spencker FB, Kiess W, Rodloff AC, Vogtmann C.
    Infection; 2002 Oct 15; 30(5):277-81. PubMed ID: 12382086
    [Abstract] [Full Text] [Related]

  • 14. Survey of CTX-M-3 extended-spectrum beta-lactamase (ESBL) among cefotaxime-resistant Serratia marcescens at a medical center in middle Taiwan.
    Wu LT, Tsou MF, Wu HJ, Chen HE, Chuang YC, Yu WL.
    Diagn Microbiol Infect Dis; 2004 Jun 15; 49(2):125-9. PubMed ID: 15183862
    [Abstract] [Full Text] [Related]

  • 15. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y, Wachino J, Ishiguro M, Kurokawa H, Yamane K, Shibata N, Shibayama K, Yokoyama K, Kato H, Yagi T, Arakawa Y.
    Antimicrob Agents Chemother; 2004 Jul 15; 48(7):2652-8. PubMed ID: 15215122
    [Abstract] [Full Text] [Related]

  • 16. Prevalence and characteristics of aac(6')-Ib-cr in AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens: a multicenter study from Korea.
    Kim SY, Park YJ, Yu JK, Kim YS, Han K.
    Diagn Microbiol Infect Dis; 2009 Mar 15; 63(3):314-8. PubMed ID: 19216942
    [Abstract] [Full Text] [Related]

  • 17. Extended-spectrum beta-lactamase-producing Serratia marcescens outbreak in a Bulgarian hospital.
    Ivanova D, Markovska R, Hadjieva N, Schneider I, Mitov I, Bauernfeind A.
    J Hosp Infect; 2008 Sep 15; 70(1):60-5. PubMed ID: 18602186
    [Abstract] [Full Text] [Related]

  • 18. First nosocomial outbreak of VIM-16-producing Serratia marcescens in Argentina.
    Nastro M, Monge R, Zintgraff J, Vaulet LG, Boutureira M, Famiglietti A, Rodriguez CH.
    Clin Microbiol Infect; 2013 Jul 15; 19(7):617-9. PubMed ID: 22862810
    [Abstract] [Full Text] [Related]

  • 19. Partial characterization of Serratia marcescens nosocomial strains.
    Coria-Jiménez VR, Villa-Tanaka L, Ortíz-Torres C.
    Arch Invest Med (Mex); 1991 Jul 15; 22(3-4):273-8. PubMed ID: 1844112
    [Abstract] [Full Text] [Related]

  • 20. High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution.
    Cartelle M, del Mar Tomas M, Molina F, Moure R, Villanueva R, Bou G.
    Antimicrob Agents Chemother; 2004 Jun 15; 48(6):2308-13. PubMed ID: 15155242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.